GlobeNewswire Inc.··DelveinsightPseudomonas Pipeline Boom: 10+ Pharma Players Race to Combat Antibiotic Resistance
DelveInsight's 2026 report reveals robust clinical pipeline for pseudomonal infections, with major pharma including AstraZeneca advancing promising therapies addressing antibiotic-resistant pathogens.
AZNARMPclinical trialscystic fibrosis